Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists. Mann JFE, Muskiet MHA. Kidney Int 2021;99:314-318.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mann JFE, Muskiet MHA. Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists. Kidney Int 2021;99:314-318.
PMID: 33509353